Abraham S - Search Results

1

Acute toxicity of tedisamil, a new potassium channel blocking drug.

Hayes E, Courtice ID, Abraham S, Walker MJ. Hayes E, et al. Among authors: abraham s. Pharmacol Toxicol. 1993 Nov;73(5):257-61. doi: 10.1111/j.1600-0773.1993.tb00581.x. Pharmacol Toxicol. 1993. PMID: 8115307

2

An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.

Pugsley MK, Saint DA, Hayes ES, Abraham S, Walker MJ. Pugsley MK, et al. Among authors: abraham s. Eur J Pharmacol. 2015 Aug 15;761:330-40. doi: 10.1016/j.ejphar.2015.06.018. Epub 2015 Jun 15. Eur J Pharmacol. 2015. PMID: 26086860

3

Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.

Beatch GN, Abraham S, MacLeod BA, Yoshida NR, Walker MJ. Beatch GN, et al. Among authors: abraham s. Br J Pharmacol. 1991 Jan;102(1):13-8. doi: 10.1111/j.1476-5381.1991.tb12124.x. Br J Pharmacol. 1991. PMID: 2043919 Free PMC article.

4

The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798.

Beatch GN, MacLeod BA, Abraham S, Walker MJ. Beatch GN, et al. Among authors: abraham s. Proc West Pharmacol Soc. 1990;33:5-8. Proc West Pharmacol Soc. 1990. PMID: 2274546 No abstract available.

5

Further studies into the ECG effects of tedisamil (KC 8857) in rats.

Howard PG, Abraham S, Courtice ID, Walker MJ. Howard PG, et al. Among authors: abraham s. Proc West Pharmacol Soc. 1989;32:183. Proc West Pharmacol Soc. 1989. PMID: 2780585 No abstract available.

6

KC8851, a tedisamil analogue with mixed channel blockade, exhibits antiarrhythmic properties against ischemia- and electrically-induced arrhythmias.

Xu R, Abraham S, McLarnon JG, Walker MJ. Xu R, et al. Among authors: abraham s. Life Sci. 1997;61(3):237-48. doi: 10.1016/s0024-3205(97)00379-2. Life Sci. 1997. PMID: 9217283

7

Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats.

Barrett TD, Hayes ES, Yong SL, Zolotoy AB, Abraham S, Walker MJ. Barrett TD, et al. Among authors: abraham s. Eur J Pharmacol. 2000 Jun 23;398(3):365-74. doi: 10.1016/s0014-2999(00)00295-8. Eur J Pharmacol. 2000. PMID: 10862826

8

Ischemic but not reperfusion arrhythmias depend upon serum potassium concentration.

Saint KM, Abraham S, MacLeod BA, McGough J, Yoshida N, Walker MJ. Saint KM, et al. Among authors: abraham s. J Mol Cell Cardiol. 1992 Jul;24(7):701-9. doi: 10.1016/0022-2828(92)93384-v. J Mol Cell Cardiol. 1992. PMID: 1404410

9

Effects of inhibition of ventricular sodium channel conductance by tetrodotoxin on the occurrence of occlusion induced arrhythmia in the rat.

Abraham S, Beatch GN, Walker MJ. Abraham S, et al. Proc West Pharmacol Soc. 1988;31:305-7. Proc West Pharmacol Soc. 1988. PMID: 2463639 No abstract available.

10

Antiarrhythmic properties of tetrodotoxin against occlusion-induced arrhythmias in the rat: a novel approach to the study of the antiarrhythmic effects of ventricular sodium channel blockade.

Abraham S, Beatch GN, MacLeod BA, Walker MJ. Abraham S, et al. J Pharmacol Exp Ther. 1989 Dec;251(3):1166-73. J Pharmacol Exp Ther. 1989. PMID: 2557414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,209 results

Search Page

Filters